Warning: This security is no longer trading.
Nasdaq Halts Sinovac Biotech Ltd. on Feb. 22, 2019
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA): Price and Financial Metrics
SVA Price/Volume Stats
| Current price | $6.47 | 52-week high | $8.75 |
| Prev. close | $6.49 | 52-week low | $5.73 |
| Day low | $6.25 | Volume | 8,200 |
| Day high | $6.58 | Avg. volume | 7,436 |
| 50-day MA | $6.64 | Dividend yield | N/A |
| 200-day MA | $7.24 | Market Cap | 368.91M |
SVA Stock Price Chart Interactive Chart >
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA) Company Bio
Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against hepatitis A, hepatitis B, influenza viruses, and mumps in the People's Republic of China. The company was founded in 1999 and is based in Beijing, China.
SVA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...